Sales Growth YoY (Last Twelve Months): Fractyl Health, Inc (GUTS)

Graphic logo of Fractyl Health, Inc (GUTS)

Investments in elite scientists and R&D have established the scientific foundation of Fractyl Health, Inc. (GUTS), as evidenced by the company's TTM revenue growth rate. The value of -100.00 represents the current metric. This served as the basis for creating the Rejuvenate platform to combat diabetes, enabling the company to aggressively displace standard injections within the overheated metabolic drug market.

Sales Growth YoY (Last Twelve Months): Fractyl (GUTS) for 11/23/2025 - 11/18/2026

Fractyl Health, Inc. (GUTS) - metric breakdowns and financial figures

- market value and analyst target forecast:
- company stock exchange capitalization indicators:
Analysis of all company metrics:Fractyl
Mass-produced product of Fractyl Health, Inc

Investors must evaluate the resilience of the Fractyl Health, Inc. (GUTS) business model through the lens of the scalability of its therapeutic solutions. Future success depends on insurance companies adopting intestinal mucosal regeneration systems as an alternative to pharmaceuticals. The annual revenue growth dynamics for the TTM period measure the percentage change in sales over the last twelve months. This indicator neutralizes seasonality, capturing the real pace of the company's expansion in the metabolic disorders market. A steady upward trend in the curve confirms the commercialization of the technologies.

Who Fractyl Health, Inc. competes with

Ascendis (ASND) - Trailing Twelve Months Revenue Growth|MDGL - Sales Growth YoY (Last Twelve Months)|CORT: Sales Growth YoY (Last Twelve Months)|RYTM: Sales Growth YoY (TTM)|AKRO - Annual Revenue Growth (Last Twelve Months)|Sales Growth YoY (Last Twelve Months) Metsera Therapeutics|MoonLake Corp (MLTX) - Annual Revenue Growth (Last Twelve Months)|Sales Growth YoY (Last Twelve Months) crinetics.com (CRNX)|Revenue Growth YoY (Last 12 Months) newamsterdampharma.com NAMS|Sales Growth YoY (Last Twelve Months) Soleno Therapeutics Inc SLNO|Sales Growth YoY (TTM) Amicus Therapeutics Inc FOLD|89bio Corp - Sales Growth YoY (TTM)|Revenue Growth Rate YoY (Last Twelve Months) Agios Pharmaceuticals Inc (AGIO)|Structure Therapeutics (GPCR) - Sales Growth YoY (Last Twelve Months)|Revenue Growth YoY (Last 12 Months) MiMedx Group, Inc.|Sales Growth YoY (Last Twelve Months) Rezolute Bio|Lexicon Pharmaceuticals, Inc. (LXRX) - Annual Revenue Growth (Last Twelve Months)|Sales Growth YoY (TTM) MBX|Revenue Growth YoY (Last 12 Months) Altimmune, Inc. ALT|Sales Growth YoY (TTM) AARD (Aardvark Pharma)|Sagimet Biosciences Inc. (SGMT) - Trailing Twelve Months Revenue Growth|BIOA: Revenue Growth YoY (Last 12 Months)|Revenue Dynamics YoY (Last Twelve Months) BMEA (Biomea Fusion)|QNCX (quincetx.com) - Revenue Growth YoY (Last 12 Months)|vTv Therapeutics, Inc. - Revenue Dynamics YoY (Last Twelve Months)|Sales Growth YoY (Last Twelve Months) Agape ATP Corp.|Revenue Growth YoY (Last 12 Months) Pluri (PLUR)|Sales Growth YoY (TTM) SYBX|Annual Revenue Growth (Last Twelve Months) Lipocine Inc|Sales Growth YoY (Last Twelve Months) Matinas BioPharma Holdings MTNB|Annual Revenue Growth (Last Twelve Months) Spruce Biosciences (SPRB)|GLTO: Revenue Growth YoY (Last 12 Months)|Trailing Twelve Months Sales Growth CTCX|LUMO (Lumos Pharma) - Revenue Growth YoY (Last 12 Months)|Sales Growth YoY (Last 12 Months) ONVO|RDUS (Radius Pharmaceuticals) - Sales Growth YoY (TTM)